InsiderTrades

Form 4 for HIMS Hims & Hers Health, Inc.

Accepted 2025-01-23 00:00:00 ET · period of report 2025-01-21 · accession 0001773751-25-000022 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-01-23 2025-01-21 HIMS Boughton Soleil CLO M - OptEx $5.01 +50.0K 219.8K +29% +$250.5K
DM 2025-01-23 2025-01-21 HIMS Boughton Soleil CLO S - Sale+OE $29.90 -54.2K 169.8K -24% -$1.62M
D 2025-01-23 2025-01-21 HIMS Boughton Soleil CLO M - OptEx $0.00 -50.0K 644.2K -7% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-01-21 M A 50,000 $5.01 219,803 D — —
2 Common Class A Common Stock 2025-01-21 S D 4,153 $28.68 165,650 D — —
3 Common Class A Common Stock 2025-01-21 S D 50,000 $30.00 169,803 D — —
4 Derivative Stock Option (right to buy) 2025-01-21 M D 50,000 $0.00 644,154 D $5.01 · — to 2032-02-23 50,000 Class A Common Stock (F2) The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 1/48th of the options vesting on March 24, 2022 and 1/48th of the options vesting monthly thereafter, subject to the Reporting Person's continuous service with the issuer.